Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2023-10-29 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
第二届监事会第二十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the supervisory board of a company, detailing the approval of the company's 2023 third quarter report and other agenda items. It references the actual third quarter report being disclosed separately on the exchange platform (announcement 2023-097). The document itself does not contain the financial report or substantive financial data but is an announcement of the meeting decisions and approvals related to the report. The document length is short (991 characters) and it serves as a formal announcement of meeting resolutions rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as the interim/quarterly report (IR) itself.
2023-10-29 Chinese
关于召开2023年第三次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the company's third extraordinary general meeting of shareholders in 2023. It details the meeting date, voting methods (including online voting), eligibility, agenda items, and registration procedures. It does not contain financial statements, audit results, or detailed management discussion. It is not a report but an announcement about a shareholders' meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-10-29 Chinese
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2023 Third Quarter Report" of Huizhou Jin Hao Medical Technology Co., Ltd. It contains detailed financial data for the nine months ending September 30, 2023, including balance sheet, income statement, cash flow statement, and explanations of significant changes. It also includes information on shareholding structure, major shareholders, stock incentive plans, share repurchase activities, and various corporate governance commitments. The document explicitly states it is a quarterly report and includes comprehensive financial data and management discussion. It is not a brief announcement or a certification letter but a full interim financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-10-29 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement about the progress of a share repurchase (buyback) program by the company. It includes specifics on the repurchase plan, pricing, quantities, funding sources, and progress updates as of a certain date. It does not contain financial statements or earnings data but focuses on the company's transactions in its own shares. This matches the definition of a 'Transaction in Own Shares' filing, which reports on share repurchase activities. The document length is 1778 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-10-08 Chinese
关于公司自验配助听器通过FDA510(k)审核的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the FDA 510(k) clearance of their self-fitting hearing aids. It describes the regulatory approval and its potential impact on the company. The document is short (856 characters) and serves as a regulatory announcement about product approval, not a financial report or detailed filing. There is no indication of financial data, management changes, voting results, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-25 Chinese
关于公司自验配助听器通过FDA510(k)审核的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the FDA 510(k) clearance of their self-fitting hearing aids. It explains the regulatory approval, its significance, and potential impact on the company. The document is short (856 characters) and serves as a regulatory announcement about product approval rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.